Lisa Avery
Neurology · Fayetteville, GANPI 1699008409
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.1% of the total across 178 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 10.4% — the pattern of someone who eats at a lot of different presentations.
Across 178 payments — averaging $22.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axsome Therapeutics, Inc.$425
- UCB, Inc.$393
- Pfizer$371
- AbbVie$367
- AstraZeneca$230
- Teva Pharmaceuticals USA, Inc.$218
- plus $2K from 26 others
What the payments were for
- Food & beverage$3,87795%
- Education$2005%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axsome Therapeutics, Inc. | 20 | $425 |
| UCB, Inc. | 23 | $393 |
| Pfizer | 19 | $371 |
| AbbVie | 22 | $367 |
| AstraZeneca(2 entities) | 6 | $230 |
| Teva Pharmaceuticals USA, Inc. | 11 | $218 |
| CSL Behring | 7 | $192 |
| Johnson & Johnson | 6 | $181 |
| EMD Serono, Inc. | 6 | $175 |
| Amgen | 3 | $164 |
| Harmony Biosciences LLC | 7 | $163 |
| Neurocrine Biosciences, Inc. | 5 | $160 |
| Jazz Pharmaceuticals Inc. | 4 | $139 |
| Neurelis, Inc. | 6 | $120 |
| SK Life Science, Inc. | 4 | $85 |
| Lundbeck LLC | 3 | $85 |
| Acadia Pharmaceuticals Inc | 3 | $85 |
| Lilly USA, LLC | 3 | $67 |
| Impel Pharmaceuticals LLC | 3 | $59 |
| Novartis | 3 | $54 |
| Amneal Pharmaceuticals LLC | 2 | $46 |
| Inspire Medical Systems, Inc. | 1 | $42 |
| Genentech USA, Inc. | 2 | $39 |
| Merz Pharmaceuticals, LLC | 1 | $37 |
| Springworks Therapeutics, Inc. | 1 | $28 |
| Sanofi | 1 | $25 |
| Scilex Pharmaceuticals Inc. | 1 | $23 |
| Argenx US, Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Kedrion Biopharma, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,076 in reported general payments places this provider in the 60th percentile of 506 neurology providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine Hcl | 12 | $1,376 |
Paid to pharmacies, not to this prescriber.
Other neurology in Fayetteville
- Kenneth LazarusFayetteville$134K
- Wallace GreenFayetteville$59K
- Virendra RanadiveFayetteville$41K
- Evan JohnsonFayetteville$30K
- Mitzi WilliamsSmyrna$1.4M
- Joash LazarusAtlanta$1.1M
- Jeffrey EnglishAtlanta$749K
- John MorganAugusta$715K
- Frank BerensonAtlanta$527K
- Julio FlaminiAtlanta$501K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.